Refreshing results…
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts
UploadGenomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer
Download from aacrjournals.orgAbstract B07: TAK228 enhances antitumor activity of eribulin in triple-negative breast cancer
Download from aacrjournals.orgTAK228 enhances antitumor activity of eribulin in triple negative breast cancer
Download from doi.orgMK-2206 window of opportunity study in breast cancer
UploadMissing publications? Search for publications with a matching author name.